New advances in hepatocellular carcinoma

Table 2 Reported 5-year overall survival and recurrence in patients undergoing liver transplant for hepatocellular carcinoma within Milan criteria

Ref.	n	5-yr overall survival	5-yr recurrence
Mazzaferro et al[155]	48	74%	8%
Bismuth et al[149]	45	74%	11%
Llovet et al[147]	79	75%	4%
Jonas et al[151]	120	71%	15%
Yao et al[158]	64	72%	6.5%
Marsh et al[153]	248	67%	3.6%
Herrero et al[154]	47	70%	8.5%
Mazzaferro et al[155]	444	73%	4.3%